These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 25978359)
1. The Involvement of Immune Semaphorins in the Pathogenesis of Inflammatory Bowel Diseases (IBDs). Vadasz Z; Rainis T; Nakhleh A; Haj T; Bejar J; Halasz K; Toubi E PLoS One; 2015; 10(5):e0125860. PubMed ID: 25978359 [TBL] [Abstract][Full Text] [Related]
2. Increased production of soluble TLR2 by lamina propria mononuclear cells from ulcerative colitis patients. Candia E; Díaz-Jiménez D; Langjahr P; Núñez LE; de la Fuente M; Farfán N; López-Kostner F; Abedrapo M; Alvarez-Lobos M; Pinedo G; Beltrán CJ; González C; González MJ; Quera R; Hermoso MA Immunobiology; 2012 Jun; 217(6):634-42. PubMed ID: 22101184 [TBL] [Abstract][Full Text] [Related]
3. CD4+ immune response as a potential biomarker of patient reported inflammatory bowel disease (IBD) activity. Brandhorst G; Weigand S; Eberle C; Raddatz D; Karaus M; Oellerich M; Walson PD Clin Chim Acta; 2013 Jun; 421():31-3. PubMed ID: 23485644 [TBL] [Abstract][Full Text] [Related]
4. The possible involvement of sema3A and sema4A in the pathogenesis of multiple sclerosis. Eiza N; Garty M; Staun-Ram E; Miller A; Vadasz Z Clin Immunol; 2022 May; 238():109017. PubMed ID: 35460904 [TBL] [Abstract][Full Text] [Related]
5. Peripheral cytokine profile in Chilean patients with Crohn's disease and ulcerative colitis. Beltrán CJ; Candia E; Erranz B; Figueroa C; Gonzalez MJ; Quera R; Hermoso MA Eur Cytokine Netw; 2009 Mar; 20(1):33-8. PubMed ID: 19318319 [TBL] [Abstract][Full Text] [Related]
6. Interleukin 35 (IL-35) and IL-37: Intestinal and peripheral expression by T and B regulatory cells in patients with Inflammatory Bowel Disease. Fonseca-Camarillo G; Furuzawa-Carballeda J; Yamamoto-Furusho JK Cytokine; 2015 Oct; 75(2):389-402. PubMed ID: 26141420 [TBL] [Abstract][Full Text] [Related]
8. Upregulation of interleukin-12 and -17 in active inflammatory bowel disease. Nielsen OH; Kirman I; Rüdiger N; Hendel J; Vainer B Scand J Gastroenterol; 2003 Feb; 38(2):180-5. PubMed ID: 12678335 [TBL] [Abstract][Full Text] [Related]
9. VEGF, basic-FGF, and TGF-beta in Crohn's disease and ulcerative colitis: a novel mechanism of chronic intestinal inflammation. Kanazawa S; Tsunoda T; Onuma E; Majima T; Kagiyama M; Kikuchi K Am J Gastroenterol; 2001 Mar; 96(3):822-8. PubMed ID: 11280558 [TBL] [Abstract][Full Text] [Related]
10. Elevated human beta-defensin-2 levels indicate an activation of the innate immune system in patients with irritable bowel syndrome. Langhorst J; Junge A; Rueffer A; Wehkamp J; Foell D; Michalsen A; Musial F; Dobos GJ Am J Gastroenterol; 2009 Feb; 104(2):404-10. PubMed ID: 19174795 [TBL] [Abstract][Full Text] [Related]
11. Lamina Propria CD4+LAP+ Regulatory T Cells Are Increased in Active Ulcerative Colitis but Show Increased IL-17 Expression and Reduced Suppressor Activity. D'Ambrosio A; Cossu A; Amendola A; Zandri A; Butera A; Sanchez M; Biffoni M; Pronio A; Montesani C; Kohn A; Pica R; Boirivant M J Crohns Colitis; 2016 Mar; 10(3):346-53. PubMed ID: 26589955 [TBL] [Abstract][Full Text] [Related]
12. Single-Cell Analyses of Colon and Blood Reveal Distinct Immune Cell Signatures of Ulcerative Colitis and Crohn's Disease. Mitsialis V; Wall S; Liu P; Ordovas-Montanes J; Parmet T; Vukovic M; Spencer D; Field M; McCourt C; Toothaker J; Bousvaros A; ; ; Shalek AK; Kean L; Horwitz B; Goldsmith J; Tseng G; Snapper SB; Konnikova L Gastroenterology; 2020 Aug; 159(2):591-608.e10. PubMed ID: 32428507 [TBL] [Abstract][Full Text] [Related]
13. Comparing the type and severity of inflammatory bowel disease in relation to IgG4 immunohistochemical staining. Şimşek HD; Basyigit S; Aktas B; Vargol E; Şimşek GG; Küçükazman M; Nazlıgül Y Acta Gastroenterol Belg; 2016; 79(2):216-21. PubMed ID: 27382941 [TBL] [Abstract][Full Text] [Related]
14. Divergent cell cycle kinetics underlie the distinct functional capacity of mucosal T cells in Crohn's disease and ulcerative colitis. Sturm A; Leite AZ; Danese S; Krivacic KA; West GA; Mohr S; Jacobberger JW; Fiocchi C Gut; 2004 Nov; 53(11):1624-31. PubMed ID: 15479683 [TBL] [Abstract][Full Text] [Related]
15. Lack of correlation between Treg quantification assays in inflammatory bowel disease patients. Brandhorst G; Petrova DT; Weigand S; Eberle C; von Ahsen N; Schmitz J; Schultze FC; Raddatz D; Karaus M; Oellerich M; Walson PD World J Gastroenterol; 2015 Mar; 21(11):3325-9. PubMed ID: 25805940 [TBL] [Abstract][Full Text] [Related]
16. The role of T cell potassium channels, KV1.3 and KCa3.1, in the inflammatory cascade in ulcerative colitis. Hansen LK Dan Med J; 2014 Nov; 61(11):B4946. PubMed ID: 25370966 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA signatures differentiate Crohn's disease from ulcerative colitis. Schaefer JS; Attumi T; Opekun AR; Abraham B; Hou J; Shelby H; Graham DY; Streckfus C; Klein JR BMC Immunol; 2015 Feb; 16():5. PubMed ID: 25886994 [TBL] [Abstract][Full Text] [Related]
18. Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation. Vivinus-Nébot M; Frin-Mathy G; Bzioueche H; Dainese R; Bernard G; Anty R; Filippi J; Saint-Paul MC; Tulic MK; Verhasselt V; Hébuterne X; Piche T Gut; 2014 May; 63(5):744-52. PubMed ID: 23878165 [TBL] [Abstract][Full Text] [Related]
19. Enterocyte dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin expression in inflammatory bowel disease. Zeng JQ; Xu CD; Zhou T; Wu J; Lin K; Liu W; Wang XQ World J Gastroenterol; 2015 Jan; 21(1):187-95. PubMed ID: 25574091 [TBL] [Abstract][Full Text] [Related]
20. Different regulation of eosinophil activity in Crohn's disease compared with ulcerative colitis. Lampinen M; Backman M; Winqvist O; Rorsman F; Rönnblom A; Sangfelt P; Carlson M J Leukoc Biol; 2008 Dec; 84(6):1392-9. PubMed ID: 18801925 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]